Cash flow NOF Corporation

Equities

4403

JP3753400005

Commodity Chemicals

Market Closed - Japan Exchange Other stock markets 12:00:00 13/03/2026 pm IST			5-day change	1st Jan Change
2,894.00 ^JPY	-0.69%		-3.39%	-3.89%

24/02	China Imposes Export Curbs on 40 Japanese Firms	MT
14/02	NOF Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI

f1913e7936aa053bdb.MQNkQSMnBg9IOMUObOtu5un4nRTcvXxL6MSIueGochM.d3MQIlJwMmUwc6NfC78Z0tmq2XaRxUkigJvBzKzPM2ACVAwuGl1ZdmUViA

Published financial data: NOF CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	17TCr	19TCr	22TCr	22TCr	24TCr
Total Revenues	17TCr	19TCr	22TCr	22TCr	24TCr
Cost of Goods Sold, Total	12TCr	12TCr	14TCr	14TCr	15TCr
Gross Profit	5.74TCr	6.89TCr	7.59TCr	7.95TCr	8.52TCr
Selling General & Admin Expenses, Total	2.59TCr	2.82TCr	2.96TCr	3.1TCr	3.28TCr
Provision for Bad Debts	1.3Cr	-1.9Cr	-	-1Cr	40L
R&D Expenses	487.3Cr	518.2Cr	569.7Cr	633.3Cr	703.1Cr
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses, Total	3.08TCr	3.33TCr	3.53TCr	3.73TCr	3.98TCr
Operating Income	2.66TCr	3.56TCr	4.06TCr	4.21TCr	4.53TCr
Interest Expense, Total	-6.1Cr	-6Cr	-8Cr	-13Cr	-14Cr
Interest And Investment Income	119.1Cr	113Cr	137.1Cr	150.7Cr	169.3Cr
Net Interest Expenses	113Cr	107Cr	129.1Cr	137.8Cr	155.6Cr
Currency Exchange Gains (Loss)	24Cr	68Cr	79Cr	153.2Cr	-32Cr
Other Non Operating Income (Expenses)	90Cr	28Cr	47Cr	52Cr	2.4Cr
EBT, Excl. Unusual Items	2.89TCr	3.76TCr	4.32TCr	4.56TCr	4.66TCr
Gain (Loss) On Sale Of Investments	536.4Cr	1.9Cr	487.4Cr	260.5Cr	365Cr
Gain (Loss) On Sale Of Assets	70L	115.4Cr	70L	10L	45Cr
Asset Writedown	-8.2Cr	-80Cr	-2.4Cr	-13Cr	-11Cr
Legal Settlements	-4.8Cr	-	-	-	-
Other Unusual Items	-20L	-2Cr	0	41Cr	22Cr
EBT, Incl. Unusual Items	3.41TCr	3.8TCr	4.8TCr	4.85TCr	5.08TCr
Income Tax Expense	1.08TCr	1.13TCr	1.4TCr	1.44TCr	1.42TCr
Earnings From Continuing Operations	2.33TCr	2.67TCr	3.4TCr	3.41TCr	3.66TCr
Net Income to Company	2.33TCr	2.67TCr	3.4TCr	3.41TCr	3.66TCr
Minority Interest	-1.3Cr	-3.1Cr	-4.2Cr	-7Cr	-11Cr
Net Income - (IS)	2.33TCr	2.67TCr	3.4TCr	3.4TCr	3.65TCr
Net Income to Common Incl Extra Items	2.33TCr	2.67TCr	3.4TCr	3.4TCr	3.65TCr
Net Income to Common Excl. Extra Items	2.33TCr	2.67TCr	3.4TCr	3.4TCr	3.65TCr
Per Share Items
Net EPS - Basic	93.5	107.92	139.01	141.17	153.88
Basic EPS - Continuing Operations	93.5	107.92	139.01	141.17	153.88
Basic Weighted Average Shares Outstanding	25Cr	25Cr	24Cr	24Cr	24Cr
Net EPS - Diluted	93.5	107.92	139.01	141.17	153.88
Diluted EPS - Continuing Operations	93.5	107.92	139.01	141.17	153.88
Diluted Weighted Average Shares Outstanding	25Cr	25Cr	24Cr	24Cr	24Cr
Normalized Basic EPS	72.35	94.95	110.26	118.02	122.27
Normalized Diluted EPS	72.35	94.95	110.26	118.02	122.27
Dividend Per Share	26.67	30	36	38	45
Payout Ratio	27.74	25.92	23.3	26.95	26.28
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	3.22TCr	4.15TCr	4.7TCr	4.91TCr	5.33TCr
EBITA	2.66TCr	3.56TCr	4.06TCr	4.21TCr	4.53TCr
EBIT	2.66TCr	3.56TCr	4.06TCr	4.21TCr	4.53TCr
Effective Tax Rate - (Ratio)	31.65	29.64	29.19	29.73	27.91
Normalized Net Income	1.8TCr	2.35TCr	2.69TCr	2.84TCr	2.9TCr
Non-Cash Pension Expense	23Cr	0	-6.3Cr	-14Cr	-38Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	536.2Cr	587.9Cr	593.9Cr	561.3Cr	621.8Cr
Research And Development Expense From Footnotes	576Cr	610.8Cr	657.3Cr	725.3Cr	792.8Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.87TCr	8.54TCr	9.25TCr	9.17TCr	8.71TCr
Total Cash And Short Term Investments	7.87TCr	8.54TCr	9.25TCr	9.17TCr	8.71TCr
Accounts Receivable, Total	4.18TCr	4.51TCr	4.88TCr	5.8TCr	6.26TCr
Total Receivables	4.18TCr	4.51TCr	4.88TCr	5.8TCr	6.26TCr
Inventory	3.23TCr	3.99TCr	4.97TCr	5.1TCr	5.73TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	241.6Cr	294Cr	270.8Cr	414.5Cr	499.5Cr
Total Current Assets	16TCr	17TCr	19TCr	20TCr	21TCr
Net Property Plant And Equipment	6.22TCr	6.19TCr	6.39TCr	7.47TCr	8.51TCr
Long-term Investments	5.22TCr	5.24TCr	4.97TCr	5.86TCr	5.7TCr
Goodwill	-	-	-	-	-
Other Intangibles, Total	99Cr	95Cr	114.8Cr	216.6Cr	195Cr
Loans Receivable Long-Term	50L	20L	50L	70L	80L
Deferred Tax Assets Long-Term	92Cr	98Cr	95Cr	114.4Cr	121.2Cr
Other Long-Term Assets, Total	10L	10L	20L	20L	10L
Total Assets	27TCr	29TCr	31TCr	34TCr	36TCr
Liabilities
Accounts Payable, Total	1.79TCr	2.18TCr	1.97TCr	2.31TCr	2.39TCr
Accrued Expenses, Total	487.8Cr	498.7Cr	510.6Cr	540.8Cr	581.9Cr
Short-term Borrowings	157Cr	199.7Cr	208Cr	160.7Cr	149Cr
Current Portion of Long-Term Debt	500Cr	280Cr	15Cr	-	82Cr
Current Portion of Leases	16Cr	13Cr	10Cr	25Cr	25Cr
Current Income Taxes Payable	631.1Cr	587.9Cr	862.6Cr	733.9Cr	768.2Cr
Other Current Liabilities	1.25TCr	1.28TCr	1.58TCr	1.64TCr	1.84TCr
Total Current Liabilities	4.84TCr	5.05TCr	5.16TCr	5.41TCr	5.83TCr
Long-Term Debt	305.3Cr	61Cr	233.2Cr	277.5Cr	200.8Cr
Long-Term Leases	16Cr	9.2Cr	18Cr	53Cr	47Cr
Pension & Other Post Retirement Benefits	500.6Cr	504Cr	489.8Cr	495.5Cr	498.4Cr
Deferred Tax Liability Non Current	1.06TCr	1.11TCr	982Cr	1.29TCr	1.16TCr
Other Non Current Liabilities	81Cr	60Cr	61Cr	23Cr	30Cr
Total Liabilities	6.8TCr	6.79TCr	6.94TCr	7.55TCr	7.76TCr
Common Stock, Total	1.77TCr	1.77TCr	1.77TCr	1.77TCr	1.77TCr
Additional Paid In Capital	1.51TCr	1.51TCr	1.51TCr	1.51TCr	1.51TCr
Retained Earnings	15TCr	17TCr	19TCr	21TCr	22TCr
Treasury Stock	-798.4Cr	-329.2Cr	-1.03TCr	-720.9Cr	-627.1Cr
Comprehensive Income and Other	2.31TCr	2.53TCr	2.46TCr	3.31TCr	3.18TCr
Total Common Equity	20TCr	22TCr	24TCr	27TCr	28TCr
Minority Interest	73Cr	78Cr	82Cr	90Cr	102.2Cr
Total Equity	20TCr	22TCr	24TCr	27TCr	28TCr
Total Liabilities And Equity	27TCr	29TCr	31TCr	34TCr	36TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	25Cr	25Cr	24Cr	24Cr	23Cr
ECS Total Common Shares Outstanding	25Cr	25Cr	24Cr	24Cr	23Cr
Book Value / Share	816.2	896.88	986.85	1.11T	1.19T
Tangible Book Value	20TCr	22TCr	24TCr	26TCr	28TCr
Tangible Book Value Per Share	812.22	893.04	982.11	1.1T	1.18T
Total Debt	994.4Cr	562.9Cr	484.3Cr	516.5Cr	504.1Cr
Net Debt	-6.87TCr	-7.98TCr	-8.77TCr	-8.66TCr	-8.2TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	206.7Cr	184.4Cr	177Cr	-84Cr	-458.1Cr
Minority Interest, Total (Incl. Fin. Div)	73Cr	78Cr	82Cr	90Cr	102.2Cr
Inventories - Raw Materials, Total	1.06TCr	1.26TCr	1.62TCr	1.87TCr	2.22TCr
Inventories - Work In Process, Total	289.8Cr	169.3Cr	341.2Cr	480.5Cr	672.2Cr
Inventories - Finished Goods, Total	1.89TCr	2.57TCr	3.01TCr	2.75TCr	2.84TCr
Full Time Employees	3.76T	3.79T	3.82T	3.88T	4T
Accumulated Allowance for Doubtful Accounts (Supple)	20Cr	18Cr	20Cr	20Cr	21Cr
Order Backlog	2.06TCr	1.7TCr	3.73TCr	4.94TCr	5.89TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	3.41TCr	3.8TCr	4.8TCr	4.85TCr	5.08TCr
Depreciation & Amortization - CF	555.3Cr	590.9Cr	635.9Cr	693.9Cr	796.5Cr
Depreciation & Amortization, Total	555.3Cr	590.9Cr	635.9Cr	693.9Cr	796.5Cr
(Gain) Loss From Sale Of Asset	3.9Cr	-41Cr	-50L	5.4Cr	-45Cr
(Gain) Loss on Sale of Investments - (CF)	-536.4Cr	-1.8Cr	-484Cr	-260.5Cr	-367Cr
Other Operating Activities, Total	-828Cr	-1.16TCr	-1.15TCr	-1.57TCr	-1.44TCr
Change In Accounts Receivable	-56Cr	-249.4Cr	-296.7Cr	-841.3Cr	-416.8Cr
Change In Inventories	274.2Cr	-730.1Cr	-941Cr	-89Cr	-598.2Cr
Change In Accounts Payable	165.6Cr	308.8Cr	-312.9Cr	251.8Cr	-23Cr
Change in Other Net Operating Assets	83Cr	222.9Cr	79Cr	-38Cr	-85Cr
Cash from Operations	3.07TCr	2.74TCr	2.33TCr	3TCr	2.9TCr
Capital Expenditure	-598.2Cr	-741.6Cr	-621.9Cr	-1.77TCr	-1.63TCr
Sale of Property, Plant, and Equipment	1.1Cr	14Cr	2.2Cr	10L	55Cr
Cash Acquisitions	-	-	-	-	-306.3Cr
Investment in Marketable and Equity Securities, Total	881Cr	22Cr	430.7Cr	331.5Cr	520.3Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	14Cr	-12Cr	22Cr	-4.6Cr	16Cr
Other Investing Activities, Total	-108.9Cr	-157.6Cr	96Cr	-49Cr	-27Cr
Cash from Investing	189.4Cr	-875.5Cr	-71Cr	-1.5TCr	-1.37TCr
Short Term Debt Issued, Total	25Cr	31Cr	-	-	-
Long-Term Debt Issued, Total	-	33Cr	220Cr	43Cr	-
Total Debt Issued	25Cr	64Cr	220Cr	43Cr	-
Short Term Debt Repaid, Total	-	-	-49Cr	-56Cr	-21Cr
Long-Term Debt Repaid, Total	-	-500Cr	-280Cr	-15Cr	-
Total Debt Repaid	-	-500Cr	-328.8Cr	-71Cr	-21Cr
Issuance of Common Stock	-	20L	-	80L	-
Repurchase of Common Stock	-165.5Cr	-387.1Cr	-700.7Cr	-752.3Cr	-1.2TCr
Common Dividends Paid	-646.5Cr	-691.9Cr	-791.6Cr	-916Cr	-959.3Cr
Common & Preferred Stock Dividends Paid	-646.5Cr	-691.9Cr	-791.6Cr	-916Cr	-959.3Cr
Other Financing Activities, Total	-17Cr	-16Cr	-16Cr	-14Cr	-20Cr
Cash from Financing	-804.2Cr	-1.53TCr	-1.62TCr	-1.71TCr	-2.2TCr
Foreign Exchange Rate Adjustments	-4Cr	151Cr	113.9Cr	52Cr	198.7Cr
Miscellaneous Cash Flow Adjustments	137.3Cr	-10L	5.5Cr	-	-
Net Change in Cash	2.59TCr	483.5Cr	764.8Cr	-157.1Cr	-480.2Cr
Supplemental Items
Cash Interest Paid	6.1Cr	6.1Cr	7.8Cr	13Cr	14Cr
Cash Income Tax Paid (Refund)	833.5Cr	1.16TCr	1.15TCr	1.57TCr	1.46TCr
Levered Free Cash Flow	2.5TCr	1.32TCr	1.59TCr	656.41Cr	1.16TCr
Unlevered Free Cash Flow	2.5TCr	1.33TCr	1.59TCr	664.48Cr	1.16TCr
Change In Net Working Capital	-879.2Cr	747.7Cr	961.4Cr	888.5Cr	829.9Cr
Net Debt Issued / Repaid	25Cr	-436.3Cr	-108.8Cr	-28Cr	-21Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.56	7.93	8.48	8.09	8.11
Return on Total Capital	8.27	10.09	10.75	10.21	10.19
Return On Equity %	12.2	12.57	14.73	13.46	13.42
Return on Common Equity	12.24	12.6	14.77	13.48	13.43
Margin Analysis
Gross Profit Margin %	33.24	35.78	34.88	35.77	35.73
SG&A Margin	15	14.62	13.61	13.96	13.77
EBITDA Margin %	18.63	21.55	21.58	22.08	22.35
EBITA Margin %	15.41	18.48	18.66	18.96	19.01
EBIT Margin %	15.41	18.48	18.66	18.96	19.01
Income From Continuing Operations Margin %	13.5	13.87	15.62	15.32	15.36
Net Income Margin %	13.5	13.85	15.6	15.29	15.31
Net Avail. For Common Margin %	13.5	13.85	15.6	15.29	15.31
Normalized Net Income Margin	10.44	12.19	12.38	12.78	12.17
Levered Free Cash Flow Margin	14.45	6.87	7.29	2.95	4.85
Unlevered Free Cash Flow Margin	14.47	6.88	7.31	2.99	4.89
Asset Turnover
Asset Turnover	0.68	0.69	0.73	0.68	0.68
Fixed Assets Turnover	2.84	3.1	3.46	3.21	2.98
Receivables Turnover (Average Receivables)	4.18	4.44	4.64	4.16	3.95
Inventory Turnover (Average Inventory)	3.43	3.43	3.16	2.83	2.83
Short Term Liquidity
Current Ratio	3.21	3.43	3.75	3.78	3.63
Quick Ratio	2.49	2.59	2.74	2.77	2.57
Operating Cash Flow to Current Liabilities	0.64	0.54	0.45	0.55	0.5
Days Sales Outstanding (Average Receivables)	87.39	82.25	78.66	87.9	92.33
Days Outstanding Inventory (Average Inventory)	106.47	106.55	115.39	129.14	129.09
Average Days Payable Outstanding	54.71	55.29	50.04	54.43	53.78
Cash Conversion Cycle (Average Days)	139.14	133.51	144.01	162.61	167.63
Long Term Solvency
Total Debt/Equity	4.89	2.54	2.02	1.94	1.8
Total Debt / Total Capital	4.66	2.48	1.98	1.91	1.77
LT Debt/Equity	1.58	0.32	1.05	1.24	0.89
Long-Term Debt / Total Capital	1.51	0.31	1.03	1.22	0.87
Total Liabilities / Total Assets	25.05	23.45	22.44	22.12	21.74
EBIT / Interest Expense	436.11	593.27	507.81	326.68	330.72
EBITDA / Interest Expense	527.15	691.75	587.3	380.47	388.86
(EBITDA - Capex) / Interest Expense	429.08	568.15	509.56	242.89	269.62
Total Debt / EBITDA	0.31	0.14	0.1	0.11	0.09
Net Debt / EBITDA	-2.14	-1.92	-1.87	-1.76	-1.54
Total Debt / (EBITDA - Capex)	0.38	0.17	0.12	0.16	0.14
Net Debt / (EBITDA - Capex)	-2.63	-2.34	-2.15	-2.76	-2.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.57	11.58	13.01	2.09	7.23
Gross Profit, 1 Yr. Growth %	-2.08	20.11	10.18	4.67	7.13
EBITDA, 1 Yr. Growth %	-0.07	29.07	13.2	4.46	8.54
EBITA, 1 Yr. Growth %	-1.01	33.8	14.13	3.73	7.52
EBIT, 1 Yr. Growth %	-1.01	33.8	14.13	3.73	7.52
Earnings From Cont. Operations, 1 Yr. Growth %	10.12	14.61	27.3	0.13	7.47
Net Income, 1 Yr. Growth %	10.23	14.54	27.29	0.05	7.38
Normalized Net Income, 1 Yr. Growth %	0.25	30.24	14.75	5.45	2.06
Diluted EPS Before Extra, 1 Yr. Growth %	11.43	15.43	28.8	1.56	9
Accounts Receivable, 1 Yr. Growth %	2.1	7.87	8.29	18.82	7.98
Inventory, 1 Yr. Growth %	-7.41	23.43	24.65	2.55	12.39
Net Property, Plant and Equip., 1 Yr. Growth %	4.98	-0.43	3.1	16.96	13.89
Total Assets, 1 Yr. Growth %	15.43	6.66	6.84	10.34	4.61
Tangible Book Value, 1 Yr. Growth %	14.08	9.01	8.2	10.42	5.23
Common Equity, 1 Yr. Growth %	13.97	8.95	8.26	10.8	5.1
Cash From Operations, 1 Yr. Growth %	10.38	-10.85	-14.82	28.44	-3.32
Capital Expenditures, 1 Yr. Growth %	-22.42	23.97	-16.14	185.38	-7.96
Levered Free Cash Flow, 1 Yr. Growth %	54.06	-46.99	19.97	-58.63	76.15
Unlevered Free Cash Flow, 1 Yr. Growth %	53.89	-46.92	20	-58.25	75.3
Dividend Per Share, 1 Yr. Growth %	2.56	12.5	20	5.56	18.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.46	3.19	12.3	7.41	4.62
Gross Profit, 2 Yr. CAGR %	-2.92	8.45	15.04	7.39	5.89
EBITDA, 2 Yr. CAGR %	-2	13.57	20.88	8.74	6.48
EBITA, 2 Yr. CAGR %	-3.29	15.09	23.58	8.81	5.61
EBIT, 2 Yr. CAGR %	-3.29	15.09	23.58	8.81	5.61
Earnings From Cont. Operations, 2 Yr. CAGR %	2.76	12.34	20.79	12.9	3.74
Net Income, 2 Yr. CAGR %	2.84	12.36	20.75	12.85	3.65
Normalized Net Income, 2 Yr. CAGR %	-1.98	14.26	22.25	10	3.74
Diluted EPS Before Extra, 2 Yr. CAGR %	4.01	13.41	21.93	14.37	5.21
Accounts Receivable, 2 Yr. CAGR %	-6.5	4.95	8.08	13.43	13.27
Inventory, 2 Yr. CAGR %	-5.5	6.9	24.04	13.06	7.36
Net Property, Plant and Equip., 2 Yr. CAGR %	3.84	2.24	1.32	9.81	15.41
Total Assets, 2 Yr. CAGR %	5.38	10.96	6.75	8.58	7.44
Tangible Book Value, 2 Yr. CAGR %	6.98	11.52	8.61	9.31	7.79
Common Equity, 2 Yr. CAGR %	6.89	11.43	8.6	9.52	7.91
Cash From Operations, 2 Yr. CAGR %	24.37	-0.8	-12.86	4.6	11.44
Capital Expenditures, 2 Yr. CAGR %	0.27	-1.93	1.96	54.7	62.07
Levered Free Cash Flow, 2 Yr. CAGR %	45.73	-9.63	-20.26	-29.55	-14.63
Unlevered Free Cash Flow, 2 Yr. CAGR %	45.53	-9.63	-20.19	-29.22	-14.45
Dividend Per Share, 2 Yr. CAGR %	1.27	7.42	16.19	12.55	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.37	0.61	6.36	8.78	7.35
Gross Profit, 3 Yr. CAGR %	-0.14	4.22	9.02	11.47	7.3
EBITDA, 3 Yr. CAGR %	1.53	7.42	13.45	15.14	8.68
EBITA, 3 Yr. CAGR %	1	7.76	14.77	16.57	8.37
EBIT, 3 Yr. CAGR %	1	7.76	14.77	16.57	8.37
Earnings From Cont. Operations, 3 Yr. CAGR %	5.45	6.57	17.12	13.47	11.06
Net Income, 3 Yr. CAGR %	5.38	6.6	17.13	13.41	10.99
Normalized Net Income, 3 Yr. CAGR %	1.64	7.76	14.43	16.37	7.29
Diluted EPS Before Extra, 3 Yr. CAGR %	6.69	7.68	18.32	14.72	12.55
Accounts Receivable, 3 Yr. CAGR %	-0.85	-1.94	6.05	11.55	11.58
Inventory, 3 Yr. CAGR %	-0.7	3.3	12.52	16.42	12.84
Net Property, Plant and Equip., 3 Yr. CAGR %	2.6	2.4	2.53	6.29	11.15
Total Assets, 3 Yr. CAGR %	4.55	5.8	9.57	7.94	7.24
Tangible Book Value, 3 Yr. CAGR %	6.35	7.65	10.4	9.21	7.93
Common Equity, 3 Yr. CAGR %	6.31	7.57	10.36	9.33	8.03
Cash From Operations, 3 Yr. CAGR %	14.98	11.31	-5.71	-0.83	1.89
Capital Expenditures, 3 Yr. CAGR %	-1.23	7.62	-6.92	43.69	30.11
Levered Free Cash Flow, 3 Yr. CAGR %	36.69	4.03	-0.68	-35.92	-4.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	36.53	3.98	-0.67	-35.7	-4.24
Dividend Per Share, 3 Yr. CAGR %	7.72	4.89	11.46	12.53	14.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.26	2.05	3.88	3.28	5.67
Gross Profit, 5 Yr. CAGR %	2.59	4.32	5.67	5.48	7.76
EBITDA, 5 Yr. CAGR %	5.71	7.36	8.86	7.95	10.61
EBITA, 5 Yr. CAGR %	6.56	7.9	9.49	8.18	11.01
EBIT, 5 Yr. CAGR %	6.56	7.9	9.49	8.18	11.01
Earnings From Cont. Operations, 5 Yr. CAGR %	11.37	8.71	11.33	9.06	11.57
Net Income, 5 Yr. CAGR %	11.39	8.7	11.28	9.06	11.54
Normalized Net Income, 5 Yr. CAGR %	7.47	8.51	9.43	8.65	10.02
Diluted EPS Before Extra, 5 Yr. CAGR %	12.91	9.87	12.54	10.31	12.9
Accounts Receivable, 5 Yr. CAGR %	2.45	3.29	2.63	3.94	8.88
Inventory, 5 Yr. CAGR %	-0.46	4.83	8.54	7.1	10.43
Net Property, Plant and Equip., 5 Yr. CAGR %	1.8	1.47	2.08	5.3	7.5
Total Assets, 5 Yr. CAGR %	6.7	5.93	5.42	6.9	8.71
Tangible Book Value, 5 Yr. CAGR %	8.51	7.79	7.25	8.31	9.35
Common Equity, 5 Yr. CAGR %	8.5	7.8	7.22	8.35	9.38
Cash From Operations, 5 Yr. CAGR %	12.69	2.66	2.91	8.57	0.8
Capital Expenditures, 5 Yr. CAGR %	2.36	6.89	0.03	24.43	16.2
Levered Free Cash Flow, 5 Yr. CAGR %	23.58	-4.77	10.18	-10.99	-6.52
Unlevered Free Cash Flow, 5 Yr. CAGR %	23.47	-4.76	10.14	-10.85	-6.43
Dividend Per Share, 5 Yr. CAGR %	17.32	15.39	11.03	7.89	11.6